Evidence map›Paper›PMID 40357788›Full record

ArticleCurrent pharmaceutical design2025

Analysis of Factors Influencing Cardiovascular Events and Mortality in Patients on Dialysis after Parathyroidectomy.

Taohong Yang, Yang Xue, Jianping Ren, XinYu Li, Wenting Xu, Guangyang Nie, Deguang Wang, Xuerong Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Current pharmaceutical design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Taohong YangDepartment of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Yang XueDepartment of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Jianping RenDepartment of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
XinYu LiDepartment of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Wenting XuDepartment of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Guangyang NieDepartment of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Deguang WangDepartment of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Xuerong WangDepartment of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Funding

Anhui Provincial Universities Outstanding Talents Cultivation Program gxgwfx2021013Clinical Research and Cultivation Program of the Second Affiliated Hospital of Anhui Medical University 2020LCYB06Health Research Program of Anhui Province AHWJ2023A20134Research Fund of Anhui Institute of translational medicine 2023zhyx-B09Research Fund of Anhui Medical University 2021xkj165University Natural Science Research Project of Anhui Province KJ2021A0314
6 · The paper itself

Abstract

backgroundRenal secondary hyperparathyroidism (SHPT) represents a prevalent complication among dialysis patients, significantly impacting long-term prognosis. Parathyroidectomy (PTX) serves as a clinically effective therapeutic option for patients diagnosed with refractory secondary hyperparathyroidism.

objectiveThis study aims to assess the impact of PTX on cardiovascular events (CVEs) and all-cause mortality in dialysis patients, as well as to analyze the incidence and potential determinants of postoperative cardiovascular events and all-cause mortality.

methodsWe collected data on 710 patients with renal secondary hyperparathyroidism who were treated with PTX between February 2011 and April 2019. A total of 633 patients who underwent PTX were finally included and matched with 462 patients who did not undergo PTX on a 1:1 basis according to age and follow-up duration. Ultimately, 179 pairs were successfully matched to investigate the differences in all-cause mortality and CVEs. The Logistic/Cox regression analyses were employed to identify independent factors associated with adverse CVEs and all-cause mortality among patients receiving PTX. Nomogram prediction models were constructed based on independent influencing factors.

resultsAmong 633 patients who underwent PTX, 117 (18.5%) died and 192 (30.3%) experienced CVEs during median 5-year follow-up. No significant differences in cardiovascular/death events were observed between matched groups. In patients who underwent PTX, the logistic regression analysis revealed that age and history of diabetes mellitus were independent risk factors for CVEs. The pre-operative use of cinacalcet and/or calcitriol was associated with a reduced risk of CVEs. With respect to preoperative and postoperative calcium levels, the highest tertile was identified as a risk factor when compared with the lowest tertile. Cox regression showed age, diabetes history, and highest preoperative phosphorus tertile negatively correlated with survival, while albumin (ALB) was positively correlated. The predictive nomogram model had an area under the receiver operating characteristic (ROC) curve of 0.649 for CVE prediction. The areas under the ROC curve for predicting 3-, 5-, and 10-year mortality prediction were 0.865, 0.865, and 0.953, respectively.

conclusionPTX does not reduce the incidence of cardiovascular events and mortality in patients on maintenance dialysis. In patients who underwent PTX, older age, a history of diabetes mellitus, and higher preoperative calcium/postoperative calcium levels were independent risk factors for adverse CVEs; preoperative use of cinacalcet and/or calcitriol was a protective risk for CVEs. Older age, a history of diabetes mellitus, lower ALB levels, and hyperphosphatemia were independent risk factors for all-cause mortality following PTX. These predictive models may assist in clinical decision-making to some extent.

Indexed as

Cardiovascular DiseasesHyperparathyroidism, SecondaryParathyroidectomyRenal DialysisRenal InsufficiencyAdultFemaleHumansIncidenceMaleMiddle AgedNomogramsRisk Factorsall-cause mortalitycardiovascular eventsdiabetes mellitus.Parathyroidectomyprediction modelsecondary hyperparathyroidism

Identifiers

PMID40357788

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.